3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
5
Phase 3
3
Phase 1/2
1
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
3
Oligodendroglioma
2
Glioma
2
Glioblastoma
2
Brain Neoplasms
2
Astrocytoma
2
Advanced Malignant Solid Tumor
2
Rhabdoid Tumor
1
Resectable Pancreatic Cancer
1
Resectable Esophageal Cancer
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Neoplasms
1
Multiple Myeloma
1
Melanoma
1
Medulloblastoma
1
Locally Advanced Pancreatic Adenocarcinoma
1
Leukemia, Plasma Cell
1
Gliosarcoma
1
Fallopian Tube Neoplasms
1
Diffuse Intrinsic Pontine Glioma
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Ductal, Breast
1
Adult Solid Neoplasm
1
Adenoma, Islet Cell
1
Interventions
Cyclophosphamide
32
Filgrastim
18
Irinotecan
15
Topotecan
14
Temozolomide
13
Vincristine
12
Peripheral Blood Stem Cell Transplantation
12
Granulocyte Colony-Stimulating Factor
12
Etoposide
12
Melphalan
11
fludarabine
10
Carboplatin
9
dinutuximab
8
Isotretinoin
8
Interleukin-2
8
Busulfan
8
humanized 3F8 anti-GD2 monoclonal antibody
7
aldesleukin
7
Doxorubicin
7
3-Iodobenzylguanidine
7
sargramostim
6
fludarabine phosphate
6
Vorinostat
6
Zoledronic Acid
5
Stem Cell Transplantation
5
Cisplatin
5
etoposide phosphate
4
Ipilimumab
4
Drug Therapy
4
ribociclib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Neuroblastoma
×
Colony-Stimulating Factors
×
Clear all
NCT05421897
2026-01-29
RAPID
Children's Hospital Los Angeles
Phase 1
Active not recruiting
11 enrolled